Blue Bell Private Wealth Management’s Loncar China BioPharma ETF CHNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-308
| Closed | -$4.39K | – | 739 |
|
|
2023
Q3 | $4.39K | Hold |
308
| – | – | ﹤0.01% | 512 |
|
|
2023
Q2 | $4.98K | Hold |
308
| – | – | ﹤0.01% | 504 |
|
|
2023
Q1 | $5.49K | Hold |
308
| – | – | ﹤0.01% | 449 |
|
|
2022
Q4 | $5.78K | Sell |
308
-141
| -31% | -$2.65K | ﹤0.01% | 444 |
|
|
2022
Q3 | $6K | Hold |
449
| – | – | ﹤0.01% | 449 |
|
|
2022
Q2 | $9K | Hold |
449
| – | – | ﹤0.01% | 403 |
|
|
2022
Q1 | $9K | Hold |
449
| – | – | ﹤0.01% | 445 |
|
|
2021
Q4 | $12K | Buy |
+449
| New | +$12K | ﹤0.01% | 379 |
|